Stock REDS REDSENSE MEDICAL AB
Add to a list
To use this feature you must be a member
Log inSign up

Financials Redsense Medical AB

Equities

REDS

SE0006965158

Medical Equipment, Supplies & Distribution

End-of-day quote NORDIC GROWTH MARKET
Other stock markets
 23:00:00 16/05/2024 BST 		5-day change 1st Jan Change
6.22 SEK -1.27% Intraday chart for Redsense Medical AB -9.33% -18.16%
05-08 Redsense Medical AB Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
02-27 Redsense Medical AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023 CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 132.8 169.2 627.6 345.4 133.1 106.7
Enterprise Value (EV) 1 130.9 161.8 562.6 321.1 122.5 99.74
P/E ratio -19.3 x -33.4 x -69.5 x -43.3 x -15.2 x -23.8 x
Yield - - 4.79% - - -
Capitalization / Revenue 15.3 x 11.9 x 36.7 x 21.1 x 7.94 x 4.18 x
EV / Revenue 15 x 11.4 x 32.9 x 19.6 x 7.31 x 3.91 x
EV / EBITDA -19.7 x -35.2 x -69.5 x -26.8 x -12.1 x -20 x
EV / FCF -31.3 x -19.2 x -88.4 x -16.7 x -12.4 x -36.6 x
FCF Yield -3.2% -5.2% -1.13% -5.99% -8.08% -2.73%
Price to Book 31 x 11.3 x 8.57 x 9.21 x 4.9 x 4.62 x
Nbr of stocks (in thousands) 10,979 12,175 14,041 14,041 14,041 14,041
Reference price 2 12.10 13.90 44.70 24.60 9.480 7.600
Announcement Date 10/05/19 01/06/20 21/04/21 06/04/22 13/04/23 16/04/24
1SEK in Million2SEK
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 8.703 14.23 17.1 16.34 16.75 25.52
EBITDA 1 -6.633 -4.591 -8.094 -11.96 -10.16 -4.975
EBIT 1 -6.829 -4.594 -8.124 -11.99 -10.21 -5.037
Operating Margin -78.47% -32.28% -47.5% -73.36% -60.93% -19.74%
Earnings before Tax (EBT) 1 -6.89 -5.071 -9.035 -7.972 -8.758 -4.513
Net income 1 -6.89 -5.071 -9.035 -7.972 -8.758 -4.513
Net margin -79.18% -35.64% -52.83% -48.77% -52.27% -17.68%
EPS 2 -0.6276 -0.4165 -0.6435 -0.5677 -0.6238 -0.3200
Free Cash Flow 1 -4.187 -8.412 -6.363 -19.22 -9.9 -2.728
FCF margin -48.11% -59.12% -37.21% -117.58% -59.09% -10.69%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - 2.140 - - -
Announcement Date 10/05/19 01/06/20 21/04/21 06/04/22 13/04/23 16/04/24
1SEK in Million2SEK
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 1.91 7.41 65 24.3 10.6 6.97
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 -4.19 -8.41 -6.36 -19.2 -9.9 -2.73
ROE (net income / shareholders' equity) -186% -52.7% -20.5% -14.4% -27.1% -18%
ROA (Net income/ Total Assets) -57% -20.4% -10.4% -12.3% -17.2% -11%
Assets 1 12.08 24.81 86.92 64.86 50.78 41.03
Book Value Per Share 2 0.3900 1.230 5.210 2.670 1.930 1.640
Cash Flow per Share 2 0.3100 0.7100 2.070 0.3500 0.2600 0.5000
Capex - 0.03 2.81 0.36 0.05 0.05
Capex / Sales - 0.19% 16.42% 2.2% 0.29% 0.2%
Announcement Date 10/05/19 01/06/20 21/04/21 06/04/22 13/04/23 16/04/24
1SEK in Million2SEK
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Annual profits - Rate of surprise

Company calendar

Sector Diagnostic & Testing Substances

1st Jan change Capi.
REDSENSE MEDICAL AB Stock Redsense Medical AB
-18.16% 8.16M
BIOMÉRIEUX Stock bioMérieux
-4.67% 12.32B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD. Stock Shenzhen New Industries Biomedical Engineering Co., Ltd.
-5.19% 8.07B
DIASORIN S.P.A. Stock DiaSorin S.p.A.
+9.45% 5.92B
LANTHEUS HOLDINGS, INC. Stock Lantheus Holdings, Inc.
+28.50% 5.52B
AUTOBIO DIAGNOSTICS CO., LTD. Stock Autobio Diagnostics Co., Ltd.
-8.09% 4.21B
10X GENOMICS, INC. Stock 10x Genomics, Inc.
-55.31% 2.99B
ANDON HEALTH CO., LTD. Stock Andon Health Co., Ltd.
+13.49% 2.73B
VITROLIFE AB Stock Vitrolife AB
-1.34% 2.43B
MYRIAD GENETICS, INC. Stock Myriad Genetics, Inc.
+32.24% 2.29B
Diagnostic & Testing Substances
  1. Stock Market
  2. Equities
  3. REDS Stock
  4. Financials Redsense Medical AB